Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch, Licensing Focus: Roche, Sanofi Exit Ongoing Anticalin Development Efforts With Pieris

16 Aug 2018

• By Joseph Haas and Eleanor Malone

DealWatch_1200x675

Related Content

Yuhan Licenses Out Degenerative Disc Therapy To Spine Despite Earlier Trial Failure

01 Aug 2018

Regeneron And Bluebird Team Up In Cell Therapy "Joint Venture"-Style Deal

06 Aug 2018

Boehringer Takes Out Option For Cystic Fibrosis Gene Therapy

06 Aug 2018

Onward Ho! Glenmark Strikes First Onco Asset Deal With China’s Harbour BioMed

06 Aug 2018

Allergan And Editas Sharpen Their CRISPR Focus On Ocular Drugs

07 Aug 2018

Aimovig And Tegsedi In Raft Of Products To Get EMA Thumbs up

01 Jun 2018

Perrigo's OTC Core Could Expand To Include National Brands

10 Aug 2018

Akcea Waylivra's Surrogate Endpoint Gains Support At US FDA Advisory Committee

11 May 2018

Related Companies

Allergan plc

Editas Medicine

Regeneron Pharmaceuticals, Inc.

Bluebird Bio

Perrigo Company PLC

Glenmark Pharmaceuticals Limited

Harbour BioMed

Boehringer Ingelheim GmbH

Roche Holding AG

Pieris Pharmaceuticals, Inc.

Sanofi

Daiichi Sankyo Co., Ltd.

AstraZeneca PLC

Les Laboratoires Servier

Seagen Inc.

Sarepta Therapeutics, Inc.

Lacerta Therapeutics, Inc.

The University of Florida Research Foundation

Acadia Pharmaceuticals Inc.

Neuren Pharmaceuticals Limited

Ionis Pharmaceuticals, Inc.

Akcea Therapeutics, Inc.

PTC Therapeutics, Inc.

Endo, Inc.

Nevakar, Inc.

Par Pharmaceutical Companies Inc.

Pfizer Inc.

Pfizer Inc.

Synergy Pharmaceuticals, Inc.

Cipher Pharmaceuticals Inc.

Additional Topics

Deals Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.